Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference106 articles.
1. Multiple sclerosis – a review
2. Secondary Progressive Multiple Sclerosis
3. The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
4. Diagnosis and Treatment of Multiple Sclerosis
5. The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel stability indicating mass compatible reversed‐phase high‐performance liquid chromatography for the determination of Diroximel fumarate and its related impurities;SEPARATION SCIENCE PLUS;2023-12-07
2. Autoimmune neurology—a rapidly evolving field;Wiener Medizinische Wochenschrift;2023-11-03
3. Is it ethical to use teriflunomide as an active comparator in phase 3 trials?;Multiple Sclerosis and Related Disorders;2023-10
4. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls;Neurology Neuroimmunology & Neuroinflammation;2023-09
5. Drug Recommender System Based on Collaborative Filtering for Multiple Sclerosis Patients;2023 9th International Conference on Web Research (ICWR);2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3